The Supreme Court decision removes that limit for now. About a week later the Fifth Circuit Court of Appeals only partially stayed the ruling, maintaining mifepristone’s approval but restricting its distribution by mail. The Department of Justice and the drug’s manufacturer, Danco Laboratories, quickly appealed the decision. Two weeks earlier Texas district judge Matthew Kacsmaryk had ruled in favor of the Alliance for Hippocratic Medicine, a group of antiabortion organizations and doctors demanding the withdrawal of mifepristone’s FDA approval. The ruling temporarily preserves access to a safe and effective abortion medication while the case goes through appeals. Last Friday the Supreme Court issued a stay on a lower court ruling that revoked the Food and Drug Administration’s more than 20-year-old approval of mifepristone, one of two medications that have been prescribed together for decades in the U.S.
0 Comments
Leave a Reply. |